site meter

search

Google

result

Showing posts with label nanotechnology. Show all posts
Showing posts with label nanotechnology. Show all posts

Thursday, September 17, 2009

Swine Flu Vaccines are Dangerous

By F. William Engdahl

Global Research, September 13, 2009

Vaccines which have been approved by the responsible government authorities for vaccination against the alleged H1N1 Influenza A Swine Flu have been found to contain nano particles. Vaccine makers have been experimenting with nanoparticles as a way to “turbo charge” vaccines for several years. Now it has come out that the vaccines approved for use in Germany and other European countries contain nanoparticles in a form that reportedly attacks healthy cells and can be deadly.

In 2007 researchers at the Ecole Polytechnique Fédérale de Lausanne (EPFL) announced in an article in the journal, Nature Biotechnology, that they had developed a “nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.” The article went on to describe the effects of their breakthrough: “At a mere 25 nanometers, these particles are so tiny that once injected, they flow through the skin’s extracellular matrix, making a beeline to the lymph nodes. Within minutes, they’ve reached a concentration of DCs thousands of times greater than in the skin. The immune response can then be extremely strong and effective.” 1

There is only one small problem with vaccines containing nanoparticles—they can be deadly and at the least cause severe irreparable health damage.

Nanoparticles, promoted in the mass media as the new wonder revolution of science, are particles that have been produced vastly smaller than deadly asbestos particles which caused severe lung damage and death before being outlawed. Particles at a nano size, (nm = 0,000000001 Meter) fuse together with the membranes of our body cell membranes and, according to recent studies in China and Japan, continuously destroy cells once introduced into the body. Once they interact with the body’s cellular structure, they cannot be removed. Modern medicine euphemistically terms the phenomenon, a continuing infectious reaction.

Since the asbestos scandal, it has been established that particles in size a millionth of a meter, because of their enormous attractive force, penetrate all cells, destroying all those they come into contact with. Nanoparticles are far smaller than asbestos fibers.

Beijing Tests confirm deadly effects on humans
The fact that WHO, the European Medicines Evaluation Agency, the German Robert Koch Institute and other health bodies today would permit the population to be injected with largely untested novel vaccines containing nanoparticles says more about the powerful pharma lobby in Euiropean politics than it does about the sanity or moral integrity of the civil servants responsible for health of the general public.




The September 2009 issue of the respected European Respiratory Journal, made public on 19 August, and available since 21 August online, contains a peer-reviewed article with the title, “Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma.”
The article describes tests carried out in 2008 at the elite Beijing Chaoyang Hospital on seven young women. All seven, ages 18-47 had been exposed to nanoparticles for 5–13 months in their common workplace. All were admitted to the hospital with shortness of breath and pleural effusions, or excessive fluids surrounding the lungs, inhibiting breathing. None of the seven had ever smoked and none were in any special risk group. Doctors carefully tested for every possibility and confirmed that the lung problems had a common origin—regular inhalation of nanoparticles in their factory. They had been exposed to Polyacrylat nanoparticles.



The tests confirmed the nanoparticles had set off a “super-meltdown” reaction in the patients. Despite all heroic efforts of doctors, two of the seven died from the lung complications. 2


In their report, the scientists concluded something so alarming it is necessary to quote at length:

“Immunological tests, examinations of bacteriology, virology and tumour markers, bronchoscopy, internal thoracoscopy and video-assisted thoracic surgery were performed. Surveys of the workplace, clinical observations and examinations of the patients were conducted. Polyacrylate, consisting of nanoparticles, was confirmed in the workplace. Pathological examinations of patients' lung tissue displayed nonspecific pulmonary inflammation, pulmonary fibrosis and foreign-body granulomas of pleura. Using transmission electron microscopy, nanoparticles were observed to lodge in the cytoplasm and caryoplasm of pulmonary epithelial and mesothelial cells, but are also located in the chest fluid. These cases arouse concern that long-term exposure to some nanoparticles without protective measures may be related to serious damage to human lungs.“3

To date Animal studies and in vitro experiments show that nanoparticles can result in lung damage and other toxicity in animals, but no reports on the clinical toxicity in humans due to nanoparticles prior to the Beijing study had been made.

The Beijing Chaoyang Hospital study has now conclusively confirmed that nanoparticles cause lung damage and other toxicity in humans as well. At this point in time, when two of the approved vaccines planned to be mass distributed in Germany and elsewhere contain nanoparticles, failure of the relevant responsible public health and epidemiology officials to order an immediate emergency freeze on distribution of any vaccine containing nanoparticles can only be considered tantamount to criminal negligence. Hopefully the responsible authorities will react in time to avert a possible human health catastrophe orders of magnitude worse than the worst case of Swine Flu reported to date.

F. William Engdahl is author of Full Spectrum Dominance: Totalitarian Democracy in the New World Order. He may be reached via his website, http://www.engdahl.oilgeopolitics.net/

Notes:

1 EPFL, Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies, accessed in www.azonano.com/nanotechnology%20news.asp?catid=13.
2 Song Y, Li X, Du X, Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma , European Respiratory Journal, 9/2009, 34(3): 559-567.
3 Ibid.
Published in
 

Tuesday, December 4, 2007

New Nanotechnology Technique for Cancer Cells


A University of California at Los Angeles (UCLA) team of scientists and researchers were able to differentiate cancer cells from normal cells using a new nanotechnology technique that "feels" the "softness" (or "stiffness") of the cells. Details of this new technique and its potential for cancer detection were published recently in the advance online edition of the leading-edge scientific journal Nature Nanotechnology.

According to the new paper, this is the first time that scientist were able to take living cells from cancer patients and, using nanotechnology, analyze them and screen which were cancerous and which were not. The new nanotechnology technique may have interesting applications for detecting cancer and may aid in giving patients more personalizing treatments protocols.

The new technique is based on measuring a rather elusive concept in cell biology: the "flexibility" of the cell. Cancerous cells must travel long distances through the body to infect other organs. These methastasic cells should become more "flexible" if they will be able to overcome all sort of physical obstacles in the blood stream and within tiny and complex cell matrices of cell tissue. The new technology can detect, at the nano level, this softness or flexibility of the cancerous cells.

Researchers at the UCLA's Jonsson Cancer Center, collected fluid samples of lung, breast and pancreatic cancer patients. Under a regular microscope cancer and normal cells looked very similar so there was no way to differentiate one cell from the other. In addition, conventional tests had 70% success rate in detecting cancerous cells (which is normal for these tests).

Rao and colleagues used a new leading edge technology known as Atomic Force Microscope (AFM) to measure cell softness. The Atomic Force Microscope utilizes a very tiny and sharp tip that pushes and feels the cell surface and determines the degree of softness. It is like a physical examination at the cell level.


The scientist found that the cancerous cells are much softer than the normal. Normal non cancerous cells are stiffer than the cancer cells and this can be succesufully detected by AFM.Softness values can be assigned to each cell to classify it as cancerous or not cancerous making diagnosis using this nanomechanical technique more accurate than traditional methods that involve killing the cells with chemicals and staining them.The study was done in a collaborative scheme between the California NanoSystems Institute, the Jonsson Cancer Center and the Departments of Chemistry and Biochemistry and Pathology and Laboratory Medicine at UCLA. This new approach will find its way through the complex web of diagnostic tools available for cancer diagnosis. Until now conventional methods are tedious, slow, and not efficient. This new nanotechnique is certainly an advance on these limitations.


Source:Rao et al. 2007. Nanomechanical analysis of cells from cancer patients. Nature Nanotechnology Published online: 2 December 2007 doi:10.1038/nnano.2007.388. URL: http://www.nature.com/nnano/journal/vaop/ncurrent/abs/nnano.2007.388.html


Published in

Popular Posts

Followers

My Travel Map

تأخير الصلاة